Dr. Howard L. Sofen, MD

Dr. Sofen practices at Howard L Sofen, MD a Medical Corporation in Los Angeles, California.

Dr. Sofen's NPI, 1124026554, was assigned on July 10, 2005. Dr. Sofen graduated from Drexel University College Of Medicine in 1981. Dr. Sofen's California license number on file is G47799.

Dr. Sofen's primary practice is Howard L Sofen, MD a Medical Corporation, at 8930 S Sepulveda Blvd, Los Angeles, CA 90045 in Los Angeles County. The practice phone is (310) 337-7171.

Dr. Sofen's primary practice is Howard L Sofen, MD a Medical Corporation in Los Angeles, California. Dr. Sofen is also affiliated with Olive View-UCLA Medical Center. The medical group on file is Howard Sofen, MD. Dmand AI also links Dr. Sofen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sofen practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Sofen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Sofen is board certified in dermatology by the American Board of Dermatology. Dr. Sofen has a license on file in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Sofen treats.

CMS data shows 1,092 Medicare services from Dr. Sofen across 12 procedure codes in 2024, for 211 Medicare patients. Medicare paid $73,168 for them. Every service was in an office.

CMS counts 211 Medicare patients who saw Dr. Sofen in 2024. The largest group is 65 to 74, with 96 patients. 71% of them have high cholesterol, and 67% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sofen's median patient age at 64, with 52% women.

In 2024, Dr. Sofen wrote 62 Medicare Part D claims for 16 patients. 61% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $76,694 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sofen for performance year 2024, reported individually. Dr. Sofen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 322 procedures of removal of skin lesions by Dr. Sofen, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Sofen, published from 2012 to 2021. 2018 was the busiest year, with 3. Dr. Sofen's most frequent co-authors are Andrew Blauvelt, MD, Mark Gabriel Lebwohl and Craig L. Leonardi, MD.

Dmand AI links Dr. Sofen to 27 clinical trials, 8 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Dermatitis, Atopic, Eczema and Psoriasis. Eli Lilly and Company sponsors the most, 10. Open Payments lists research payments to Dr. Sofen that name 16 trials.

CMS Open Payments shows 927 general payments to Dr. Sofen from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 34% of the total. Sun Pharmaceutical Industries Inc. paid the most, $155,979. It also lists 80 research payments totaling $124,328 from 2016 to 2024, naming 16 clinical trials.

Dmand AI lists 1 award for Dr. Sofen.

Dr. Sofen graduated from Drexel University College Of Medicine in 1981. Dr. Sofen is a member of AAD.

Dr. Sofen is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.